AB
MTEM

Amalgamated Bank’s Molecular Templates, Inc. MTEM Stock Holding History

Amalgamated Bank’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-401
Closed -$21K – 3282
2022
Q1 		$21K Buy
+401
New +$17.7K ﹤0.01% 2806

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amalgamated Bank's MTEM Position: Q2 2022 in Review

Amalgamated Bank sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 401 shares — an estimated $21K sold.

Amalgamated Bank first reported a position in MTEM in Q1 2022 and held it in 1 quarter. The position peaked at $21K in Q1 2022. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • Amalgamated Bank reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 401 Molecular Templates, Inc. shares in Q2 2022, an estimated $21K.
  • Amalgamated Bank first reported a position in Molecular Templates, Inc. in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Molecular Templates, Inc. position peaked at $21K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.